DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB18193
| null |
VCN-01
| null | null | null | null |
DB18194
| null |
Efocipegtrutide
|
2513399-19-2
|
TUI1MDD9F6
|
GLUCAGON ANALOG CONJUGATED WITH HUMAN IMMUNOGLOBULIN G4 FRAGMENT | HM15211 (LONG-ACTING GLP-1/GIP/GLUCAGON TRIPLE AGONIST) | IMMUNOGLOBULIN G4 (HUMAN .GAMMA.4-CHAIN C REGION C-TERMINAL FRAGMENT), DIMER, 1-(1-(3-HYDROXYPROPYL)-L-PROLINE), 1-ETHER WITH .ALPHA.-(3-((3-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOPROPYL)AMINO)PROPYL)-.OMEGA.-HYDROXYPOLY(OXY-1,2-ETHANEDIYL), THIOETHE
| null |
DB18195
| null |
Canoctakin
|
1019859-03-0
|
MU4128F2CO
|
Glycafilin | Interleukin 8 (synthetic human clone dncxcl8 increased-glycosaminoglycan binding isoform pa401) | Recombinant dna derived, human interleukin 8 (cxcl8) mutein, produced in escherichia coli: (44,48,97,98-tetra-l-lysine)human interleukin 8 precursor-(34-99)- peptide anti-inflammatory
| null |
DB18196
| null |
GX-G8
| null | null | null | null |
DB18197
| null |
ST-003
|
143896-17-7
|
HSN8WK37D7
|
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu- Gly-Pro-Pro-Pro-Ala-Leu-Ala-Leu-Ala-NH2 | L-Alaninamide, glycyl-L-tryptophyl-L-threonyl-L-leucyl-L-asparaginyl-L-seryl-L-alanylglycyl-L-tyrosyl-L-leucyl-L-leucylglycyl-L-prolyl-L-prolyl-L-prolyl-L-alanyl-L-leucyl-L-alanyl-L-leucyl-
| null |
DB18198
| null |
OM-301
| null | null |
Glycine, L-prolyl-L-prolyl-L-leucyl-L-seryl-L-glutaminyl-L-alpha-glutamyl-L-threonyl-Lphenylalanyl- L-seryl-L-alpha-aspartyl-L-leucyl-L-tryptophyl-L-lysyl-L-leucyl-L-leucyl-L-lysyl-Llysyl- L-tryptophyl-L-lysyl-L-methionyl-L-arginyl-L-arginyl-L-asparaginy | Pro-Pro-Leu-Ser-Gln-Gln-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-Lys-Lys-Trp-Lys-Met- Arg-Arg-Asn-Gln-Phe-Trp-Val-Lys-Val-Gln-Arg-Gly
| null |
DB18199
| null |
BBP-711
| null | null | null | null |
DB18200
| null |
Golexanolone
|
2089238-18-4
|
9C48F08TP2
|
Androstan-17-one, 3-ethynyl-3-hydroxy-, oxime, (3.beta.,5.alpha.,17e)-
|
FFIBGVYTWNPLPN-BZLGYYABSA-N
|
DB18201
| null |
ACT-1 peptide
| null |
LQO3A9PGE4
|
ACTI PEPTIDE | GRANEXIN | GRANEXIN PEPTIDE | PEPTIDE 328967
| null |
DB18202
| null |
Ilixadencel
| null |
PY29292DVJ
| null | null |
DB18203
| null |
Cudetaxestat
|
1782070-21-6
|
6B7TYB2MJX
|
3-((2,6-dichloro-7-fluoro-1-(1-propyl-1h-pyrazol-4-yl)-1h-indol-3-yl)thio)-2-fluorobenzoic acid | Benzoic acid, 3-((2,6-dichloro-7-fluoro-1-(1-propyl-1h-pyrazol-4-yl)-1h-indol-3-yl)thio)-2-fluoro- | BLD-0409 | Cudetaxestat
|
NMDFAQXLJQRHMS-UHFFFAOYSA-N
|
DB18204
| null |
SER-287
| null | null | null | null |
DB18205
| null |
GRObeta
| null | null |
GROβ
| null |
DB18206
| null |
AP-102
|
846569-60-6
|
EW91FWW4HC
|
H-(4-amino-3-iodo)-d-phe-c(cys-(3-iodo)-tyr-d-trp-lys-val-cys)-thr-nh2 | H-(4-amino-3-iodo)-D-Phe-c[Cys-(3-iodo)-Tyr-D-Trp-Lys-Val-Cys]-Thr-NH2 | L-threoninamide, 4-amino-3-iodo-d-phenylalanyl-l-cysteinyl-3-iodo-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl-l-cysteinyl-, cyclic (2->7)-disulfide
|
ISZMJWBQCGWNNM-FJOHFWBCSA-N
|
DB18207
| null |
Eneboparatide
|
1349298-00-5
|
K6E9SY8U8D
| null | null |
DB18208
| null |
DOTA-Arg-Pro-Lys-Pro-Gln-Gln-Phe-2Thi-Gly-Leu-Met(O2)-NH2 Actinium AC-225
|
2230254-48-3
|
44S7GN2UDJ
|
[225Ac]Butanamide, N2-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-arginyl-L-prolyl-L-lysyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-phenylalanyl-3-(2-thienyl)-L-alanylglycyl-L-leucyl-2-amino-4-(methylsulfonyl)-, (2S)- | DOTA-2Thi-Met(O2)-Substance P analog Actinium AC-225 | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-2Thi-Gly-Leu-Met(O2)-NH2-DOTA-225-actinium
|
FMQURNZNWLIWQS-BCAUDCSCSA-K
|
DB18209
| null |
NX-210c
|
216682-41-6
|
8U8J5ASV94
|
Glycine, L-tryptophyl-L-serylglycyl-L-tryptophyl-L-seryl-L-seryl-L-cysteinyl-L-seryl-L-arginyl-L-seryl-L-cysteinyl- | H-L-tryphophanyl-L-seryl-glycyl-L-tryptophanyl-L-seryl-L-seryl-L-cysteinyl-L-seryl-L-arginyl-L-seryl-L-cysteinyl-glycyl-OH (disulfide bond) | SCO-Spondin Derived Peptide NX210
| null |
DB18210
| null |
Gresonitamab
|
2413817-97-5
|
0SIB91V6TP
|
IMMUNOGLOBULIN, BISPECIFIC, ANTI-(HUMAN CLAUDIN 18.2) (HUMAN MONOCLONAL HWZV_KLA_L SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HU
| null |
DB18211
| null |
Vepsitamab
|
2413453-53-7
|
ZR1EEO1ZLS
|
IMMUNOGLOBULIN, BISPECIFIC, ANTI-(HUMAN MUCIN 17) (HUMAN MONOCLONAL MUC17_CD3_ALT2 SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HU
| null |
DB18212
| null |
Ifinatamab deruxtecan
|
2484870-92-8
|
C6I0GC0GX5
|
IMMUNOGLOBULIN G1, ANTI-(HUMAN B7 HOMOLOG 3 PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL MABX-9001A .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MABX-9001A .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOH | MABX-9001A CYSTEINYL-DERUXTECAN
| null |
DB18213
| null |
Idroxioleic acid
|
56472-29-8
|
OSV3KVO1BT
|
(z)-2-hydroxyoctadec-9-enoic acid | 2-hydroxyoleic acid | 9-octadecenoic acid, 2-hydroxy-, (9z)- | Alpha-hydroxyoleic acid | Cis-2-hydroxy-9-octadecenoic acid | Minerval | Rac-(2r,9z)-2-hydroxyoctadec-9-enoic acid
|
JBSOOFITVPOOSY-KTKRTIGZSA-N
|
DB18214
| null |
Ibutamoren
|
159634-47-6
|
GJ0EGN38UL
|
2-amino-n-((r)-2-(benzyloxy)-1-((1-(methylsulfonyl)spiro(indoline-3,4'-piperidin)-1'-yl)carbonyl)ethyl)-2-methylpropionamide | 2-amino-n-(3-(benzyloxy)-1-(1-methanesulfonyl-1,2-dihydrospiro(indole-3,4'-piperidin)-1'-yl)-1-oxopropan-2-yl)-2-methylpropanamide
|
UMUPQWIGCOZEOY-JOCHJYFZSA-N
|
DB18215
| null |
LP-184
|
924835-67-6
|
L683VC69K8
|
(R)-1-HYDROXY-1-((6'-HYDROXY-2',4',6'-TRIMETHYL-7'-OXO-6',7'-DIHYDROSPIRO(CYCLOPROPANE-1,5'-INDEN)-3'-YL)METHYL)UREA | Hydroxyurea methylacylfulvene | N-(((6'R)-6',7'-DIHYDRO-6'-HYDROXY-2',4',6'-TRIMETHYL-7'-OXOSPIRO(CYCLOPROPANE-1,5'-(5H)INDEN)-3'-YL)METHYL)-N-HYDROXYUREA | N-HYDROXY-N-(METHYLACYLFULVENE)UREA | UREA, N-(((6'R)-6',7'-DIHYDRO-6'-HYDROXY-2',4',6'-TRIMETHYL-7'-OXOSPIRO(CYCLOPROPANE-1,5'-(5H)INDEN)-3'-YL)METHYL)-N-HYDROXY-
|
VWMPVAZEBAKLFR-HNNXBMFYSA-N
|
DB18216
| null |
Cavrotolimod
|
2378664-12-9
|
2Z5JOV1PPN
|
DNA, D(P-THIO)(T-C-G-T-C-G-T-T-T-T-G-T-C-G-T-T-T-T-G-T-C-G-T-T), 3'-(58-((3.BETA.)-CHOLEST-5-EN-3-YLOXY)-19,39,42-TRIHYDROXY-19,39-DIOXIDO-58-OXO-3,6,9,12,15,18,20,23,26,29,32,35,38,40,44,47,50,53-OCTADECAOXA-57-AZA-19,39-DIPHOSPHAOCTAPENTACONT-1-YL HYDR
| null |
DB18217
| null |
Haptoglobulin 1/1 (Plasma Derived)
| null | null |
Haptoglobin (Hp1-1), (Human)
| null |
DB18218
| null |
FCX-013
| null | null | null | null |
DB18219
| null |
Osemitamab
|
2460539-61-9
|
H14V1A2F4D
|
IMMUNOGLOBULIN G1, ANTI-(HUMAN CLAUDIN 18.2) (HUMAN-MUS MUSCULUS MONOCLONAL TST001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL TST001 .KAPPA.-CHAIN, DIMER
| null |
DB18220
| null |
Indralin
|
156691-86-0
|
ACF4F9H44I
|
2-thiophenecarboxylic acid, 5-((1e)-2-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-1-propen-1-yl)- | 5-((1e)-2-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-1-propen-1-yl)-2-thiophenecarboxylic acid | Indraline
|
QPAMXNZWXFZISY-SDNWHVSQSA-N
|
DB18221
| null |
Tagitanlimab
|
2417649-97-7
|
GUY458P83P
|
Immunoglobulin g1 (237-alanine,238-alanine,240-alanine), anti-(human programmed death-ligand 1) (human monoclonal kla167 .gamma.1-chain), disulfide with human monoclonal kla167 .kappa.-chain, dimer
| null |
DB18222
| null |
INO-3107
| null | null | null | null |
DB18223
| null |
KB407
| null | null | null | null |
DB18224
| null |
KB105
| null |
7RJ7NSG7A0
| null | null |
DB18225
| null |
TSHA-104
| null | null | null | null |
DB18226
| null |
Belcesiran
|
2375562-54-0
|
9ET5DMZ3AW
|
Dcr-a1at
| null |
DB18227
| null |
Andusomeran
|
2918977-08-7
|
4F9QRS7ZV2
|
COVID-19 mRNA vaccine, monovalent (XBB.1.5 Variant) | CX-038839 Omicron (XBB.1.5)
| null |
DB18228
| null |
Raxtozinameran
| null | null |
Comirnaty Omicron XBB.1.5
| null |
DB18229
| null |
Hemopexin
| null | null |
BETA-1B-GLYCOPROTEIN | HEMOPEXIN (HUMAN)
| null |
DB18230
| null |
XMT-2056
| null | null | null | null |
DB18231
| null |
DF-1001
| null | null |
Heterodimeric multi-specific IgG1 antibody targeting human epidermal growth factor receptor 2 (HER2) and NKG2D on natural killer (NK) and cytotoxic T-cells
| null |
DB18232
| null |
Hexasodium phytate
|
34367-89-0
|
ZBX50UG81V
|
(1r,2r,3s,4s,5r,6s)-cyclohexane-1,2,3,4,5,6-hexayl-hexakis(dihydrogen phosphate) | Hexasodium fytate | Inositol, hexakis(dihydrogen phosphate) hexasodium salt, myo- | Myo-inositol, hexakis(dihydrogen phosphate), hexasodium salt
|
DHZIAGCFFSRULK-BQYPOXACSA-H
|
DB18233
| null |
IBIO-100
| null | null | null | null |
DB18234
| null |
AP103
| null | null | null | null |
DB18235
| null |
CKD-504
| null | null | null | null |
DB18236
| null |
(R)-9b
|
1655527-68-6
| null | null | null |
DB18237
| null |
Nerandomilast
|
1423719-30-5
|
I5DGT51IB8
|
BI-1015550
|
UHYCLWAANUGUMN-SSEXGKCCSA-N
|
DB18238
| null |
Hexapeptide-2
|
87616-84-0
|
4H7N4I6X6A
|
Growth hormone releasing hexapeptide | Growth hormone-releasing peptide 6 | Hexapeptide 2 | His-d-trp-ala-trp-d-phe-lys nh2 | His-d-trp-ala-trp-d-phe-lys-nh2 | L-lysinamide, l-histidyl-d-tryptophyl-l-alanyl-l-tryptophyl-d-phenylalanyl-
| null |
DB18239
| null |
ONL-1204
|
2040964-58-5
|
XNA75YDV3F
|
His-his-ile-tyr-leu-gly-ala-val-asn-tyr-ile-tyr-nh2
| null |
DB18240
| null |
MK-2225
| null | null |
Homodimeric fragment crystallizable fusion protein comprised of the extracellular domain of the human transforming growth factor beta receptor type II linked to a human IgG1 Fc domain
| null |
DB18241
| null |
TLR-AD1
| null | null | null | null |
DB18242
| null |
SPK-7001
| null | null | null | null |
DB18243
| null |
M012
| null | null | null | null |
DB18244
| null |
Zapnometinib
|
303175-44-2
|
4RZD8LK83V
|
Benzoic acid, 2-((2-chloro-4-iodophenyl)amino)-3,4-difluoro-
|
XCNBGWKQXRQKSA-UHFFFAOYSA-N
|
DB18245
| null |
Zandelisib
|
1401436-95-0
|
8Z28M5SX0X
|
1,3,5-triazin-2-amine, 4-(2-(difluoromethyl)-1h-benzimidazol-1-yl)-n-(1,1-dimethyl-2-(2-(1-methyl-4-piperidinyl)phenyl)ethyl)-6-(4-morpholinyl)- | 4-(2-(difluoromethyl)benzimidazol-1-yl)-n-(1,1-dimethyl-2-(2-(1-methyl-4-piperidyl)phenyl)ethyl)-6-morpholino-1,3,5-triazin-2-amine
|
WPFUFWIHMYZXSF-UHFFFAOYSA-N
|
DB18246
| null |
Rencofilstat
|
1383420-08-3
|
M3H4D91AY5
| null |
KBARHGHBFILILC-NGIJKBHDSA-N
|
DB18247
| null |
BD-111
| null | null | null | null |
DB18248
| null |
Mefuparib
|
1392502-82-7
|
9NN2OZ1YX4
|
5-fluoro-2-(4-((methylamino)methyl)phenyl)-7-benzofurancarboxamide | Cvl-218 free base
|
ROBJKLPZIPNAMV-UHFFFAOYSA-N
|
DB18249
| null |
Nadunolimab
| null |
ND296JF21I
| null | null |
DB18250
| null |
Nanvuranlat
|
1037592-40-7
|
CEDO9QXYZK
|
(2s)-2-amino-3-(4-((5-amino-2-phenyl-1,3-benzoxazol-7-yl)methoxy)-3,5-dichloro-phenyl)propanoic acid | L-tyrosine, o-((5-amino-2-phenyl-7-benzoxazolyl)methyl)-3,5-dichloro- | O-((5-amino-2-phenyl-1,3-benzoxazol-7-yl)methyl)-3,5- dichloro-l-tyrosine
|
XNRZJPQTMQZBCE-SFHVURJKSA-N
|
DB18251
| null |
Opelconazole
|
1931946-73-4
|
45LU8Q6ASU
|
D-threo-pentitol, 2,5-anhydro-1,3,4-trideoxy-2-c-(2,4-difluorophenyl)-4-((4-(4-(4-(((4-fluorophenyl)amino)carbonyl)phenyl)-1-piperazinyl)-2-methylphenoxy)methyl)-1-(1h-1,2,4-triazol-1-yl)- | Opelconazole(inn)
|
OSAMZQJKSCAOHA-CWRQMEKBSA-N
|
DB18252
| null |
Pralmorelin
|
158861-67-7
|
E6S6E1F19M
|
D-ala-3-(2-naphthyl)-d-ala-ala-trp-d-phe-lys-nh2 | D-alanyl-3-(2-naphthyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-l-lysinamide | Growth hormone-releasing peptide 2 | L-lysinamide, d-alanyl-3-(2-naphthalenyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-
|
HRNLPPBUBKMZMT-RDRUQFPZSA-N
|
DB18253
| null |
AMP-101
| null | null |
Adeno-associated virus serotype 9 vector encoding the Dok7 protein
| null |
DB18254
| null |
OAV401
| null | null | null | null |
DB18255
| null |
ET-101
| null | null | null | null |
DB18256
| null |
VGM-R02b
| null | null | null | null |
DB18257
| null |
EXOB-001
| null | null | null | null |
DB18258
| null |
DR-01
| null | null |
Human anti-CD94 IgG1 monoclonal antibody (non-fucosylated)
| null |
DB18259
| null |
Human autologous bone marrow derived osteoblastic cells
| null | null |
PREOB
| null |
DB18260
| null |
MRT5005
| null | null | null | null |
DB18261
| null |
C134
| null | null | null | null |
DB18262
| null |
DCN-tCRK
| null | null | null | null |
DB18263
| null |
TBX-1400
| null | null | null | null |
DB18264
| null |
BREN-02
| null | null | null | null |
DB18265
| null |
Human glial progenitor cells
| null | null | null | null |
DB18266
| null |
HM15912
| null | null | null | null |
DB18267
| null |
Ferroheme
|
14875-96-8
|
42VZT0U6YR
|
Heme | HEME B | HEME IRON | PROTOHEME | PROTOHEME IX
|
KABFMIBPWCXCRK-RGGAHWMASA-L
|
DB18268
| null |
TAK-075 Free base
|
667931-25-1
|
4B002AUC52
|
Pyrazolo(1,5-a)pyrimidine-3-carboxamide, n-(1-ethyl-1-(4-ethylphenyl)propyl)-4,5,6,7-tetrahydro-2,7,7-trimethyl-5-phenyl-, (5r)-
|
UEEHORXWFOHMHK-XMMPIXPASA-N
|
DB18269
| null |
Insulin B-chain vaccine
| null | null | null | null |
DB18270
| null |
A-16L
|
410527-75-2
|
0UHG2WF4HP
|
ALA-GLN-TYR-ILE-LYS-ALA-ASN-SER-LYS-PHE-ILE-GLY-ILE-THR-GLU-LEU | L-ALANYL-L-GLUTAMINYL-L-TYROSYL-L-ISOLEUCYL-L-LYSYL-L-ALANYL-L-ASPARAGINYL-L-SERYL-L-LYSYL-L-PHENYLALANYL-L-ISOLEUCYLGLYCYL-L-ISOLEUCYL-L-THREONYL-L-.ALPHA.-GLUTAMYL-L-LEUCINE | L-LEUCINE, L-ALANYL-L-GLUTAMINYL-L-TYROSYL-L-ISOLEUCYL-L-LYSYL-L-ALANYL-L-ASPARAGINYL-L-SERYL-L-LYSYL-L-PHENYLALANYL-L-ISOLEUCYLGLYCYL-L-ISOLEUCYL-L-THREONYL-L-.ALPHA.-GLUTAMYL- | MAVEROPEPIMUT-S COMPONENT A16L | MODIFIED TETANUS TOXIN PEPTIDE, 830-844 (AL-16L) | T-HELPER ANTIGEN A16L
| null |
DB18271
| null |
VTX-803
| null | null | null | null |
DB18272
| null |
LX-1004
| null | null | null | null |
DB18273
| null |
LX2006
| null | null | null | null |
DB18274
| null |
SP-101
| null | null | null | null |
DB18275
| null |
Iluzanebart
|
2733621-19-5
|
23Q5AU2MD5
|
gamma1 heavy chain Homo sapiens (1-451) [VH (Homo sapiens IGHV5-51*01 (96.9%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT [8.8.14] (26-33.51-58.97-110)) (1-121) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14, G1v54-30 CH2 C83, G84.4, C85 (CH1 R | Immunoglobulin G1 [296-cysteine,301-glycine,306-cysteine], anti-(human triggering receptor expressed on myeloid cells 2) (human monoclonal VGL101 γ1-chain), disulfide with human monoclonal VGL101 κ-chain, dimer
| null |
DB18276
| null |
OT-004
| null | null | null | null |
DB18277
| null |
OCU400
| null | null |
AAV-hNR2E3
| null |
DB18278
| null |
DB-OTO
| null | null | null | null |
DB18279
| null |
Protego-PD
| null | null | null | null |
DB18280
| null |
TSHA-101
| null | null |
adeno-associated viral vector serotype 9 (AAV9) carrying both HEXA and HEXB
| null |
DB18281
| null |
Ulviprubart
|
2569434-60-0
|
QT44II3WZP
|
Anti-klrg1 (afucosylated, humanized igg1) | gamma1 heavy chain humanized (1-449) [VH humanized (Homo sapiens IGHV1-8*01 (81.6%) -(IGHD) -IGHJ5*01 (86.7%), CDR-IMGT [8.8.12] (26-33.51-58.97-108)) (1-119) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 (CH1 R120>K (216) (120-217), hinge 1-15 (218-232), C | immunoglobulin G1-kappa, anti-[Homo sapiens KLRG1(killer cell lectin like receptor G1, MAFA, CLEC15A)], humanized monoclonal antibody | Immunoglobulin G1, anti-(human killer cell lectin-like receptor subfamily G member 1) (human-Mus musculus monoclonal ABC008 γ1-chain), disulfide with human-Mus musculus monoclonal ABC008 κ-chain, dime
| null |
DB18282
| null |
Izaflortaucipir
|
2173361-80-1
|
MWJ7I16SUJ
|
2-(2-fluoropyridin-4-yl)-9h-pyrrolo(2,3-b:4,5-c')dipyridine | 9h-pyrido(3',4':4,5)pyrrolo(2,3-b)pyridine, 2-(2-fluoro-4-pyridinyl)-
|
JUPWIBZGGFVBCU-UHFFFAOYSA-N
|
DB18283
| null |
LM-030
|
1122484-55-2
|
31I6DBK5RW
|
(S)-2-ISOBUTYRYLAMINO-PENTANEDIOIC ACID 5-AMIDE 1-{[(2S,5S,8S,11R,12S,15S,18S,21R)-2,8-BIS-((S)-SEC-BUTYL)-21-HYDROXY-5-(4-HYDROXY-BENZYL)-15-ISOBUTYL-4,11-DIMETHYL-3,6,9,13,16,22-HEXAOXO-10-OXA-1,4,7,14,17-PENTAAZA-BICYCLO[16.3.1]DOCOS-12-YL]-AMIDE | L-ISOLEUCINE, N2-(2-METHYL-1-OXOPROPYL)-L-GLUTAMINYL-L-THREONYL-L-LEUCYL-(.ALPHA.S,3S,6R)-3-AMINO-6-HYDROXY-.ALPHA.-((1S)-1-METHYLPROPYL)-2-OXO-1-PIPERIDINEACETYL-N-METHYL-L-TYROSYL-, (6->2)-LACTONE
|
QZEXRDYEZBKQHM-TULYSKAASA-N
|
DB18284
| null |
CT-001
| null | null |
Human recombinant factor VIIa variant (P10Q, K32E, T106N, V253N), desialylated
| null |
DB18285
| null |
AD-114
| null | null |
Human single domain antibody-like protein inhibitor of the chemokine receptor type 4
| null |
DB18286
| null |
BVX-20
| null | null | null | null |
DB18287
| null |
AO-176
| null | null | null | null |
DB18288
| null |
CT041
| null | null | null | null |
DB18289
| null |
OBI-888
|
2227156-40-1
|
JI5TBH62QP
|
Anti-globo h monoclonal antibody obi-888
| null |
DB18290
| null |
Anvatabart opadotin
|
2636710-07-9
|
B2KH16FA7H
|
Arx-788 (anti-her2 mab paf- mmaf toxin oxime conjugate) | gamma1 heavy chain humanized (1-449) [VH humanized (Homo sapiens IGHV3-66*01 (81.6%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*01, G1m17,1 (CH1 A1.4>F (pAF) (121), K120 (217) (121- 218), hinge 1-15 (219 | Immunoglobulin G1 [121-(4-acetylphenylalanine),de-450-lysine], anti-(human epidermal growth factor receptor HER2) (human-Mus musculus monoclonal Amab788 γ1-chain), disulfide with human-Mus musculus monoclonal Amab788 κ-chain, dimer, 121,121′-dioxime | Immunoglobulin G1-kappa, anti-[Homo sapiens ERBB2 (epidermal growth factor receptor 2, receptor tyrosine-protein kinase erbB-2, EGFR2, HER2, HER-2, p185c-erbB2, NEU, CD340)], humanized monoclonal antibody; conjugated at two engineered sites via a stable
| null |
DB18291
| null |
Ulenistamab
|
2415259-90-2
|
HX998WER5A
|
Immunoglobulin g1, anti-(human pancreatic adenocarcinoma up-regulated factor) (human-mus musculus monoclonal pbp1510 .gamma.1-chain), disulfide with human-mus musculus monoclonal pbp1510 .kappa.-chain, dimer
| null |
DB18292
| null |
4A10
| null | null |
Anti-interleukin-7 Receptor α Monoclonal antibody
| null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.